ClinicalTrials.Veeva

Menu

Heart Rate Variability & Fatty Acid Status: Haemodialysis Patients

K

King's College London

Status

Completed

Conditions

Chronic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02014792
DNS9195677

Details and patient eligibility

About

Studies suggest that dietary omega-3 fatty acids influence the extent to which the time interval between each heart beat varies (heart rate variability; HRV). Low HRV is associated with increased risk of sudden cardiac death (SCD). The purpose of this research is to investigate the relationship between 24 hour parameters of HRV and blood omega-3 fatty acid levels in patients who have recently commenced haemodialysis.

Enrollment

52 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CKD stage 5 commencing haemodialysis,
  • male or female,
  • aged 40-80 y,
  • written informed consent

Exclusion criteria

  • history of chronic liver disease or neuropathy, infection or antibiotics within the last month.

Trial design

52 participants in 1 patient group

Chronic kidney disease, stage 5
Description:
Patients with stage 5 chronic kidney disease who have recently commenced haemodialysis treatment (within 6-10 weeks of starting treatment)

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems